The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 1095-1099

  Parthasarathy, Anand ^a,b   Cheung, Michael K ^a   Osann, Kathryn ^c   Husain, Amreen ^a   Teng, Nelson N ^a   Berek, Jonathan S ^a   Kapp, Daniel S ^a   Chan, John K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Positive node; Radiotherapy; Stage III; Survival; Vulvar cancer

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ASIAN; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; HISPANIC; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RACE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VULVA CARCINOMA; VULVECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INGUINAL CANAL; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 33751507642     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.06.030     Document Type: Article

References (27)

1. Edwards B.K., Brown M.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 97 (2005) 1407-1427
2. Messing M.J., and Gallup D.G. Carcinoma of the vulva in young women. Obstet. Gynecol. 86 (1995) 51-54
3. Ansink A. Vulvar squamous cell carcinoma. Semin. Dermatol. 15 (1996) 51-59
4. Homesley H.D., Bundy B.N., Sedlis A., and Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet. Gynecol. 68 (1986) 733-740
5. Moore D.A., Koh W.J., McGuire W.P., Wilkinson E.J., and Vulva. In: Hoskins W.J., Perez C.A., Young R.C., Barakat R.R., Markman M., and Randall M.E. (Eds). Principles and practices of gynecologic cancers (2005), Lippincott Williams & Wilkins, Philadelphia, PA
6. Surveillance, Epidemiology, and End Results Program, SEER*Stat Database: Incidence-SEER 12 Regs Public-Use, Nov 2004 Sub (1988-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at: . Released April 2005.
7. Creasman W.T., Phillips J.L., and Menck H.R. The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 80 (1997) 505-513
8. Burke T.W., Levenback C., Coleman R.L., Morris M., Silva E.G., and Gershenson D.M. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol. Oncol. 57 (1995) 215-220
9. Origoni M., Sideri M., Garsia S., Carinelli S.G., and Ferrari A.G. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol. Oncol. 45 (1992) 313-316
10. Burger M.P., Hollema H., Emanuels A.G., Krans M., Pras E., and Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol. Oncol. 57 (1995) 327-334
11. Paladini D., Cross P., Lopes A., and Monaghan J.M. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 74 (1994) 2491-2496
12. van der Velden J., van Lindert A.C., Lammes F.B., et al. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75 (1995) 2885-2890
13. Piver M.S., Tsukada Y., Werness B.A., DiCioccio R.A., Whittemore A.S., and Ponder B.A. Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Gynecol. Oncol. 78 (2000) 166-170
14. Tyler Jr. C.W., Lee N.C., Robboy S.J., et al. The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists?. Am. J. Obstet. Gynecol. 164 (1991) 65-70
15. Maggard M.A., O'Connell J.B., Lane K.E., Liu J.H., Etzioni D.A., and Ko C.Y. Do young breast cancer patients have worse outcomes?. J. Surg. Res. 113 (2003) 109-113
16. Virnig B.A., Warren J.L., Cooper G.S., Klabunde C.N., Schussler N., and Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med. Care 40 (2002) IV-49-54
17. Cooper G.S., Virnig B., Klabunde C.N., Schussler N., Freeman J., and Warren J.L. Use of SEER-Medicare data for measuring cancer surgery. Med. Care 40 (2002) IV-43-8
18. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 (1999) 1154-1161
19. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 (1999) 1144-1153
20. Lanciano R., Calkins A., Bundy B.N., et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study. J. Clin. Oncol. 23 (2005) 8289-8295
21. Buda A., Fossati R., Colombo N., et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J. Clin. Oncol. 23 (2005) 4137-4145
22. Cunningham M.J., Goyer R.P., Gibbons S.K., Kredentser D.C., Malfetano J.H., and Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol. Oncol. 66 (1997) 258-261
23. Berek J.S., Heaps J.M., Fu Y.S., Juillard G.J., and Hacker N.F. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol. Oncol. 42 (1991) 197-201
24. Koh W.J., Chiu M., Stelzer K.J., et al. Femoral vessel depth and the implications for groin node radiation. Int. J. Radiat. Oncol. Biol. Phys. 27 (1993) 969-974
25. Montana G.M., and Kang S.K. Carcinoma of the vulva. In: Perez C.A., Brady L.W., Halperin E.C., and Schmidt-Ullrich R.K. (Eds). Principles and practice of radiation oncology (2004), Lippincott Williams & Wilkins, Philadelphia, PA
26. Hankey B.F., Ries L.A., and Edwards B.K. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 1117-1121
27. North American Association of Central Cancer Registries. Available at: . 2003.